Elicio Therapeutics Inc. • ELTX

Capital at risk.

About Elicio Therapeutics Inc.
Ticker
info
ELTX
Trading on
info
NASDAQ
ISIN
info
US28657F1030
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Robert T. Connelly
Headquarters
info
451 D Street, Boston, MA, United States, 02210
Employees
info
32
Website
info
https://elicio.com
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$127M
P/E ratio
info
-
EPS
info
-$3.97
Dividend Yield
info
0.00%
Beta
info
2.16
Forward P/E ratio
info
0
EBIDTA
info
$-45.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$127M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
14.21
Earnings
EPS
info
-$3.97
EPS estimate (current quarter)
info
-$0.83
EPS estimate (next quarter)
info
-$0.66
EBITDA
info
$-45.2M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
2.16
52-week High
info
$9.99
52-week Low
info
$3.35
50-day moving average
info
$6.65
200-day moving average
info
$6.21
Short ratio
info
6.31
Short %
info
2.66%
Management effectiveness
ROE (TTM)
info
-744.59%
ROA (TTM)
info
-108.03%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
16M
Float
info
10.3M
Insiders %
info
45.12%
Institutions %
info
10.45%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$11.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.64
-$0.96
33.33%
Q2 • 24Beat
-$1.39
-$0.73
-90.41%
Q3 • 24Missed
-$1.02
-$0.88
-16.57%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.2M
$-14M
-1,201.03%
Q4 • 24
$0M
$-11.2M
-∞%
Q1 • 25
-100.00%
-19.96%
∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$28.2M
$39.5M
140.14%
Q4 • 24
$28.1M
$19.2M
68.36%
Q1 • 25
-0.12%
-51.28%
-51.22%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-8.7M
$-0M
$0.2M
$-8.8M
Q4 • 24
$-10.1M
$0M
$10.3M
$-10.1M
Q1 • 25
15.73%
-100.00%
4,449.78%
15.13%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Elicio Therapeutics Inc. share?
Collapse

Elicio Therapeutics Inc. shares are currently traded for undefined per share.

How many shares does Elicio Therapeutics Inc. have?
Collapse

Elicio Therapeutics Inc. currently has 16M shares.

Does Elicio Therapeutics Inc. pay dividends?
Collapse

No, Elicio Therapeutics Inc. doesn't pay dividends.

What is Elicio Therapeutics Inc. 52 week high?
Collapse

Elicio Therapeutics Inc. 52 week high is $9.99.

What is Elicio Therapeutics Inc. 52 week low?
Collapse

Elicio Therapeutics Inc. 52 week low is $3.35.

What is the 200-day moving average of Elicio Therapeutics Inc.?
Collapse

Elicio Therapeutics Inc. 200-day moving average is $6.21.

Who is Elicio Therapeutics Inc. CEO?
Collapse

The CEO of Elicio Therapeutics Inc. is Robert T. Connelly.

How many employees Elicio Therapeutics Inc. has?
Collapse

Elicio Therapeutics Inc. has 32 employees.

What is the market cap of Elicio Therapeutics Inc.?
Collapse

The market cap of Elicio Therapeutics Inc. is $127M.

What is the P/E of Elicio Therapeutics Inc.?
Collapse

The current P/E of Elicio Therapeutics Inc. is null.

What is the EPS of Elicio Therapeutics Inc.?
Collapse

The EPS of Elicio Therapeutics Inc. is -$3.97.

What is the PEG Ratio of Elicio Therapeutics Inc.?
Collapse

The PEG Ratio of Elicio Therapeutics Inc. is null.

What do analysts say about Elicio Therapeutics Inc.?
Collapse

According to the analysts Elicio Therapeutics Inc. is considered a buy.